Abacus Life Reports Third Quarter 2024 Results
Abacus Life (NASDAQ: ABL) reported Q3 2024 results with total revenue growing 33% year-over-year to $28.1 million. Despite posting a GAAP net loss of $5.1 million due to a non-cash warrant liability increase, the company achieved significant growth metrics with Adjusted Net Income up 65% to $14.9 million and Adjusted EBITDA rising 54% to $16.7 million. Policy originations increased 54% to 278, with capital deployment of $93.2 million. The company is advancing its ABL Tech platform with over 20 clients and progressing on acquisitions of Carlisle Management and FCF Advisors, expected to add $2.6 billion in assets under management.
Abacus Life (NASDAQ: ABL) ha riportato i risultati del terzo trimestre 2024, con un aumento del fatturato totale del 33% rispetto all'anno precedente, raggiungendo $28,1 milioni. Nonostante una perdita netta conforme ai principi contabili GAAP di $5,1 milioni a causa di un aumento della responsabilità per warrant non monetari, l'azienda ha registrato metriche di crescita significative, con un reddito netto corretto in aumento del 65% a $14,9 milioni e un EBITDA corretto in crescita del 54% a $16,7 milioni. Le nuove polizze emesse sono aumentate del 54% arrivando a 278, con un impiego di capitale di $93,2 milioni. L'azienda sta sviluppando la sua piattaforma ABL Tech con oltre 20 clienti e progredendo nell'acquisizione di Carlisle Management e FCF Advisors, che si prevede aggiungeranno $2,6 miliardi in attivi gestiti.
Abacus Life (NASDAQ: ABL) reportó los resultados del tercer trimestre de 2024, con un aumento del 33% en los ingresos totales interanuales, alcanzando $28.1 millones. A pesar de registrar una pérdida neta conforme a GAAP de $5.1 millones debido a un aumento en la responsabilidad por warrants no monetarios, la compañía logró métricas de crecimiento significativas, con ingreso neto ajustado aumentando un 65% a $14.9 millones y EBITDA ajustado aumentando un 54% a $16.7 millones. Las originaciones de pólizas crecieron un 54% hasta 278, con un despliegue de capital de $93.2 millones. La empresa está avanzando en su plataforma ABL Tech con más de 20 clientes y progresando en las adquisiciones de Carlisle Management y FCF Advisors, que se espera que añadan $2.6 mil millones en activos bajo gestión.
Abacus Life (NASDAQ: ABL)는 2024년 3분기 결과를 보고했으며, 총 수익이 전년 대비 33% 증가하여 $28.1 백만에 달했습니다. 비현금 워런트 책임 증가로 GAAP 기준에서 $5.1 백만의 순손실을 기록했음에도 불구하고, 회사는 조정 순이익이 65% 증가하여 $14.9 백만, 조정 EBITDA가 54% 상승하여 $16.7 백만에 도달하는 등 знач覧 성과를 보였습니다. 정책 발행이 54% 증가하여 278건에 이르고, 자본 투자는 $93.2 백만에 달합니다. 이 회사는 20명 이상의 고객과 함께 ABL Tech 플랫폼을 발전시키고 있으며, 크리스탈 매니지먼트와 FCF 어드바이저의 인수를 진행 중이며, 이는 $26억의 자산을 추가할 것으로 예상됩니다.
Abacus Life (NASDAQ: ABL) a publié ses résultats pour le troisième trimestre 2024, avec un chiffre d'affaires total en hausse de 33% par rapport à l'année précédente, atteignant 28,1 millions de dollars. Malgré une perte nette selon les normes GAAP de 5,1 millions de dollars en raison d'une augmentation de la responsabilité des warrants non monétaires, l'entreprise a affiché des indicateurs de croissance significatifs, avec un revenu net ajusté en hausse de 65% à 14,9 millions de dollars et un EBITDA ajusté augmentant de 54% à 16,7 millions de dollars. Les origines de polices ont augmenté de 54%, atteignant 278, avec un déploiement de capital de 93,2 millions de dollars. L'entreprise fait progresser sa plateforme ABL Tech avec plus de 20 clients et avance dans l'acquisition de Carlisle Management et FCF Advisors, ce qui devrait ajouter 2,6 milliards de dollars d'actifs sous gestion.
Abacus Life (NASDAQ: ABL) berichtete über die Ergebnisse des dritten Quartals 2024, wobei der Gesamtumsatz im Jahresvergleich um 33% auf 28,1 Millionen USD wuchs. Trotz eines GAAP-Nettoverlusts von 5,1 Millionen USD aufgrund eines Anstiegs der nicht zahlungswirksamen Verbindlichkeiten bei Warrants erzielte das Unternehmen bedeutende Wachstumskennzahlen, mit einem bereinigten Nettogewinn, der um 65% auf 14,9 Millionen USD anstieg und einem bereinigten EBITDA, das um 54% auf 16,7 Millionen USD stieg. Die Policenausstellungen stiegen um 54% auf 278, bei einer Kapitaleinsetzung von 93,2 Millionen USD. Das Unternehmen entwickelt seine ABL Tech-Plattform mit über 20 Kunden weiter und arbeitet an der Übernahme von Carlisle Management und FCF Advisors, die voraussichtlich 2,6 Milliarden USD an verwaltetem Vermögen hinzufügen werden.
- Revenue growth of 33% YoY to $28.1 million
- Adjusted Net Income increased 65% YoY to $14.9 million
- Adjusted EBITDA grew 54% YoY to $16.7 million
- Policy originations up 54% to 278 policies
- Capital deployment increased to $93.2 million from $56.4 million YoY
- Pending acquisitions to add $2.6 billion in assets under management
- Strong ROIC and ROE at 21% and 23% respectively
- GAAP net loss of $5.1 million vs. net income of $0.9 million in prior year
- $7.8 million increase in warrant liability loss
- $1.5 million increase in interest expense
- Outstanding long-term debt of $166.5 million
Insights
Strong quarterly performance with
Strategic moves are compelling - pending acquisitions of Carlisle Management and FCF Advisors will add
The ABL Tech platform's rapid client acquisition (20 current, 23 in pipeline) in just 8 months demonstrates strong market validation. The PREADISAN™ partnership enhances competitive positioning in longevity forecasting, a growing niche in alternative investments.
The
- Delivered Continued Revenue and Profitability Growth While Executing on Strategic Initiatives -
- Third Quarter 2024 Total Revenue Grows
- Due to Non-Cash Increase in Warrant Liability of
- Adjusted Net Income Grows
- Adjusted EBITDA Grows
ORLANDO, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, today reported results for the third quarter ended September 30, 2024.
“It was another great quarter for Abacus as we continued to deliver meaningful growth and profitability, while we successfully executed on our long-term strategy,” said Jay Jackson, Chief Executive Officer of Abacus. “Along with our excellent results, we are thrilled with the significant advancements we have made with our ABL Tech platform, which already serves over 20 clients, with 23 more either committed or in negotiations, in just eight months since launch. We also made substantial progress in terms of our announced acquisitions of Carlisle Management and FCF Advisors, which together will add about
Third Quarter 2024 Highlights
- Total revenue for the third quarter of 2024 grew
33% to$28.1 million , compared to$21.1 million in the prior-year period. The increase was primarily driven by higher active management revenue, increased capital deployed and more policies sold directly to third parties. - Origination capital deployment for the third quarter of 2024 was
$93.2 million , compared to$56.4 million in the prior-year period; number of policy originations for the third quarter of 2024 grew54% to 278, compared to 181 in the prior-year period. - GAAP net loss attributable to shareholders for the third quarter of 2024 was
$5.1 million , compared to net income of$0.9 million in the prior-year period, primarily driven by a non-cash$7.8 million increase in loss on change in fair value of warrant liability, a$1.8 million increase in expenses related to employee stock compensation and a$1.5 million increase in interest expense. - Adjusted net income (a non-GAAP financial measure) for the third quarter of 2024 grew
65% to$14.9 million , compared to$9.0 million in the prior-year period. Adjusted diluted earnings per share for the third quarter of 2024 was$0.20 , compared to$0.14 in the prior-year period. - Adjusted EBITDA (a non-GAAP financial measure) for the third quarter of 2024 grew
54% to$16.7 million , compared to$10.8 million in the prior-year period. Adjusted EBITDA margin (a non-GAAP financial measure) for the third quarter of 2024 was59.2% , compared to51.1% in the prior-year period. - Annualized return on invested capital (ROIC) (a non-GAAP financial measure) for the third quarter of 2024 was
21% . - Annualized Return on equity (ROE) (a non-GAAP financial measure) for the third quarter of 2024 was
23% .
Liquidity and Capital
As of September 30, 2024, the Company had cash and cash equivalents of
Webcast and Conference Call
A webcast and conference call to discuss the Company’s results will be held today beginning at 5:00 p.m. (Eastern Time). A live webcast of the conference call will be available on Abacus’ investor relations website at ir.abacuslife.com. The dial-in number for the conference call is (800) 267-6316 (toll-free) or (203) 518-9783 (international), followed by the required Conference ID: ABACUS. Please dial the number 10 minutes prior to the scheduled start time.
A webcast replay of the call will be available at ir.abacuslife.com for one year following the call.
Non-GAAP Financial Information
Adjusted Net Income, a non-GAAP financial measure, is defined as net income (loss) attributable to Abacus adjusted for non-controlling interest income, amortization, change in fair value of warrants and non-cash stock-based compensation and the related tax effect of those adjustments. Management believes that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance. A reconciliation of Adjusted Net Income to Net income attributable to Abacus, the most directly comparable GAAP measure, appears below.
Adjusted EBITDA, a non-GAAP financial measure, is defined as net income (loss) attributable to Abacus adjusted for depreciation expense, amortization, interest expense, income tax and other non-cash and certain non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate to business performance within Abacus’ control. A reconciliation of Adjusted EBITDA to Net income attributable to Abacus Life, the most directly comparable GAAP measure, appears below.
Adjusted EBITDA margin, a non-GAAP financial measure, is defined as Adjusted EBITDA divided by Total revenues. A reconciliation of Adjusted EBITDA margin to Net income margin, the most directly comparable GAAP measure, appears below.
Annualized return on invested capital (ROIC), a non-GAAP financial measure, is defined as Adjusted net income for the quarter divided by the result of Total Assets less Intangible assets, net, Goodwill and Current Liabilities multiplied by four. ROIC is not a measure of financial performance under GAAP. We believe ROIC should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP.
Annualized return on equity (ROE), a non-GAAP financial measure, is defined as Adjusted net income divided by total shareholder equity multiplied by four. ROE is not a measure of financial performance under GAAP. We believe ROE should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP. The below table presents our calculation of ROE.
Forward-Looking Statements
All statements in this press release (and oral statements made regarding the subjects of this press release) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from such statements, many of which are outside the control of Abacus. Forward-looking information includes but is not limited to statements regarding: Abacus’s financial and operational outlook; Abacus’s operational and financial strategies, including planned growth initiatives and the benefits thereof, Abacus’s ability to successfully effect those strategies, and the expected results therefrom. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” “prospects,” “will,” “would,” “will continue,” “will likely result,” and similar expressions (including the negative versions of such words or expressions).
While Abacus believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance or results of its business. The factors that could cause results to differ materially from those indicated by such forward-looking statements include, but are not limited to: the fact that Abacus’s loss reserves are bases on estimates and may be inadequate to cover its actual losses; the failure to properly price Abacus’s insurance policies; the geographic concentration of Abacus’s business; the cyclical nature of Abacus’s industry; the impact of regulation on Abacus’s business; the effects of competition on Abacus’s business; the failure of Abacus’s relationships with independent agencies; the failure to meet Abacus’s investment objectives; the inability to raise capital on favorable terms or at all; the effects of acts of terrorism; and the effectiveness of Abacus’s control environment, including the identification of control deficiencies.
These forward-looking statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties set forth in documents filed by Abacus with the U.S. Securities and Exchange Commission from time to time, including the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent periodic reports. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Abacus cautions you not to place undue reliance on the forward-looking statements contained in this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Abacus assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Abacus does not give any assurance that it will achieve its expectations.
About Abacus
Abacus is a pioneering global alternative asset manager and market maker specializing in uncorrelated financial products. The company leverages its proprietary, cutting-edge longevity data and actuarial technology to purchase life insurance policies from consumers seeking liquidity. This creates a high-return asset class uncorrelated to market fluctuations for institutional investors.
With nearly
Abacus is expanding its leading expertise in longevity and lifespan into new growth areas:
- ABL Wealth - Leverages decades of data and proprietary algorithms to offer longevity-based wealth management platforms that enable financial advisors to create customized plans and provide access to uncorrelated investments.
- ABL Tech - A groundbreaking technology service that delivers advanced real-time data tracking and analysis for pension funds, governments, insurance companies, retirement associations, and more.
Through each new channel, Abacus is revolutionizing the future of asset management and financial planning, centered on longevity and lifespan.
Contacts :
Investor Relations
Robert F. Phillips – SVP Investor Relations and Corporate Affairs
rob@abacuslife.com
(321) 290-1198
David Jackson – IR/Capital Markets Associate
djackson@abacuslife.com
(321) 299-0716
Abacus Life Public Relations
press@abacuslife.com
| ABACUS LIFE, INC. Consolidated Balance Sheets | |||||||
| September 30, 2024 (unaudited) | December 31, 2023 | ||||||
| ASSETS | |||||||
| CURRENT ASSETS: | |||||||
| Cash and cash equivalents | $ | 19,409,615 | $ | 25,588,668 | |||
| Equity securities, at fair value | 3,019,055 | 2,252,891 | |||||
| Accounts receivable | 2,232,432 | 2,149,111 | |||||
| Accounts receivable, related party | 83,498 | 79,509 | |||||
| Due from affiliates | 1,279,099 | 1,007,528 | |||||
| Income tax receivable | 2,702,103 | — | |||||
| Prepaid expenses and other current assets | 2,070,875 | 699,127 | |||||
| Total current assets | 30,796,677 | 31,776,834 | |||||
| Property and equipment, net | 888,519 | 400,720 | |||||
| Intangible assets, net | 24,653,141 | 29,623,130 | |||||
| Goodwill | 139,930,190 | 140,287,000 | |||||
| Operating right-of-use assets | 2,033,538 | 1,893,659 | |||||
| Life settlement policies, at cost | 1,071,172 | 1,697,178 | |||||
| Life settlement policies, at fair value | 273,249,493 | 122,296,559 | |||||
| Available-for-sale securities, at fair value | 1,185,740 | 1,105,935 | |||||
| Other investments, at cost | 1,850,000 | 1,650,000 | |||||
| Other assets | 1,650,698 | 998,945 | |||||
| Equity securities, at fair value | — | 96,107 | |||||
| TOTAL ASSETS | $ | 477,309,168 | $ | 331,826,067 | |||
| LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) | |||||||
| CURRENT LIABILITIES: | |||||||
| Current portion of long-term debt, at fair value | $ | 13,730,026 | $ | 13,029,632 | |||
| Accrued expenses | 2,535,277 | 4,354,225 | |||||
| Accounts payable | — | — | |||||
| Operating lease liabilities | 413,071 | 118,058 | |||||
| Due to affiliates | — | 5,236 | |||||
| Due to former members | — | 1,159,712 | |||||
| Contract liabilities, deposits on pending settlements | 924,083 | 507,000 | |||||
| Accrued transaction costs | 2,600,000 | — | |||||
| Other current liabilities | 3,659,891 | 3,400,734 | |||||
| Income taxes payable | — | 751,734 | |||||
| Total current liabilities | 23,862,348 | 23,326,331 | |||||
| Long-term debt, related party | 12,157,258 | 37,653,869 | |||||
| Long-term debt, net | 57,996,997 | 33,818,090 | |||||
| Long-term debt, at fair value, net | 96,358,740 | 55,318,923 | |||||
| Operating lease liabilities | 1,860,736 | 1,796,727 | |||||
| Deferred tax liability | 12,003,461 | 9,199,091 | |||||
| Warrant liability | 15,130,000 | 6,642,960 | |||||
| TOTAL LIABILITIES | 219,369,540 | 167,755,991 | |||||
| COMMITMENTS AND CONTINGENCIES (Note 12) | |||||||
| STOCKHOLDERS' EQUITY | |||||||
| Preferred stock, | — | — | |||||
| Class A common stock, | 7,576 | 6,339 | |||||
| Treasury stock - at cost; 1,048,226 and 146,650 shares repurchased at September 30, 2024 and December 31, 2023, respectively | (12,025,137 | ) | (1,283,062 | ) | |||
| Additional paid-in capital | 309,655,378 | 199,826,278 | |||||
| Accumulated deficit | (39,639,373 | ) | (34,726,135 | ) | |||
| Accumulated other comprehensive income | 32,721 | 108,373 | |||||
| Noncontrolling interest | (91,537 | ) | 138,283 | ||||
| Total stockholders' equity | 257,939,628 | 164,070,076 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 477,309,168 | $ | 331,826,067 | |||
[1] The 2023 number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.
ABACUS LIFE, INC. Interim Unaudited Consolidated Statement of Operations
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| REVENUES: | |||||||||||||||
| Portfolio servicing revenue | $ | 116,386 | $ | 224,569 | $ | 539,209 | $ | 814,626 | |||||||
| Active management revenue | 26,967,575 | 18,926,144 | 73,778,331 | 39,921,061 | |||||||||||
| Origination revenue | 1,064,530 | 1,970,217 | 4,394,237 | 1,970,217 | |||||||||||
| Total revenues | 28,148,491 | 21,120,930 | 78,711,777 | 42,705,904 | |||||||||||
| COST OF REVENUES (excluding depreciation and amortization stated below) | |||||||||||||||
| Cost of revenue (including stock-based compensation) | 2,187,551 | 3,356,976 | 7,649,844 | 4,819,926 | |||||||||||
| Related party cost of revenue | 430 | 7,981 | 2,568 | 7,981 | |||||||||||
| Total cost of revenue | 2,187,981 | 3,364,957 | 7,652,412 | 4,827,907 | |||||||||||
| Gross Profit | 25,960,510 | 17,755,973 | 71,059,365 | 37,877,997 | |||||||||||
| OPERATING EXPENSES: | |||||||||||||||
| Sales and marketing | 2,169,197 | 1,704,154 | 6,651,942 | 3,116,999 | |||||||||||
| General and administrative (including stock-based compensation) | 15,489,503 | 9,838,951 | 41,396,346 | 11,113,382 | |||||||||||
| Loss on change in fair value of debt | 124,237 | (2,088,797 | ) | 4,036,327 | 309,865 | ||||||||||
| Unrealized loss (gain) on investments | (417,677 | ) | 306,800 | (1,220,161 | ) | (491,356 | ) | ||||||||
| Realized gain on investments | - | - | (856,744 | ) | - | ||||||||||
| Depreciation and amortization expense | 1,745,279 | 1,694,853 | 5,177,785 | 1,696,994 | |||||||||||
| Total operating expenses | 19,110,539 | 11,455,961 | 55,185,495 | 15,745,884 | |||||||||||
| Operating Income | 6,849,971 | 6,300,012 | 15,873,870 | 22,132,113 | |||||||||||
| OTHER INCOME (EXPENSE): | |||||||||||||||
| Loss on change in fair value of warrant liability | (8,766,500 | ) | (943,400 | ) | (8,487,040 | ) | (943,400 | ) | |||||||
| Interest expense | (4,218,314 | ) | (2,679,237 | ) | (12,417,946 | ) | (3,620,695 | ) | |||||||
| Interest income | 609,496 | 63,826 | 1,670,828 | 71,283 | |||||||||||
| Other (expense) income | (9,832 | ) | 20,086 | 132,610 | (1,565 | ) | |||||||||
| Total other (expense) | (12,385,150 | ) | (3,538,725 | ) | (19,101,548 | ) | (4,494,377 | ) | |||||||
| Net (loss) income before provision for income taxes | (5,535,179 | ) | 2,761,287 | (3,227,678 | ) | 17,637,736 | |||||||||
| Income tax (benefit) expense | (250,368 | ) | 1,710,315 | 2,680,855 | 2,238,419 | ||||||||||
| NET (LOSS) INCOME | (5,284,811 | ) | 1,050,972 | (5,908,533 | ) | 15,399,317 | |||||||||
| LESS: NET (LOSS) INCOME ATTRIBUTABLE TO NONCONTROLLING INTEREST | (159,756 | ) | 147,611 | (204,716 | ) | (339,692 | ) | ||||||||
| NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS | (5,125,055 | ) | 903,361 | (5,703,817 | ) | 15,739,009 | |||||||||
| (LOSS) EARNINGS PER SHARE: | |||||||||||||||
| (Loss) earnings per share - basic [1] | $ | (0.07 | ) | $ | 0.01 | $ | (0.09 | ) | $ | 0.29 | |||||
| (Loss) earnings per share - diluted [1] | $ | (0.07 | ) | $ | 0.01 | $ | (0.09 | ) | $ | 0.29 | |||||
| Weighted-average stock outstanding—basic [1] | 74,694,319 | 63,349,823 | 66,984,401 | 54,632,826 | |||||||||||
| Weighted-average stock outstanding—diluted [1] | 74,694,319 | 63,349,823 | 66,984,401 | 54,632,826 | |||||||||||
[1] The 2023 number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.
ABACUS LIFE, INC. Adjusted Net Income and Adjusted EPS
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||
| NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS | $ | (5,125,055 | ) | $ | 903,361 | $ | (5,703,817 | ) | $ | 15,739,009 | ||||
| Amortization expense | 1,698,983 | 1,682,083 | 5,072,125 | 1,682,083 | ||||||||||
| Stock-based compensation | 6,416,378 | 4,583,632 | 18,675,208 | 4,583,632 | ||||||||||
| Business acquisition costs | 1,948,118 | — | 3,273,118 | — | ||||||||||
| Loss on change in fair value of warrant liability | 8,766,500 | 943,400 | 8,487,040 | 943,400 | ||||||||||
| Tax impact [1] | 1,174,328 | 908,271 | 3,518,782 | 908,271 | ||||||||||
| Adjusted Net Income | $ | 14,879,252 | $ | 9,020,747 | $ | 33,322,456 | $ | 23,856,395 | ||||||
| Weighted-average shares of Class A common stock outstanding - basic [2] | 74,694,319 | 63,349,823 | 66,984,401 | 54,632,826 | ||||||||||
| Weighted-average shares of Class A common stock outstanding - diluted [2] | 74,694,319 | 63,349,823 | 66,984,401 | 54,632,826 | ||||||||||
| Adjusted EPS - basic | $ | 0.20 | $ | 0.14 | $ | 0.50 | $ | 0.44 | ||||||
| Adjusted EPS - diluted | $ | 0.20 | $ | 0.14 | $ | 0.50 | $ | 0.44 | ||||||
[1] Tax impact represents the permanent difference in tax expense related to the restricted stock awards granted to the CEO due to IRC 162(m) limitations.
[2] The 2023 number of shares outstanding have been retrospectively recast for prior period presented to reflect the outstanding stock of Abacus Life, Inc. as a result of the Business Combination.
ABACUS LIFE, INC. Adjusted EBITDA
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| NET (LOSS) INCOME | $ | (5,284,811 | ) | $ | 1,050,972 | $ | (5,908,533 | ) | $ | 15,399,317 | ||||||
| Depreciation and amortization expense | 1,745,279 | 1,694,853 | 5,177,785 | 1,696,994 | ||||||||||||
| Income tax (benefit) expense | (250,368 | ) | 1,710,315 | 2,680,855 | 2,238,419 | |||||||||||
| Interest expense | 4,218,314 | 2,679,237 | 12,417,946 | 3,620,695 | ||||||||||||
| Other (income) expense | 9,832 | (20,086 | ) | (132,610 | ) | 1,565 | ||||||||||
| Interest income | (609,496 | ) | (63,826 | ) | (1,670,828 | ) | (71,283 | ) | ||||||||
| Loss on change in fair value of warrant liability | 8,766,500 | 943,400 | 8,487,040 | 943,400 | ||||||||||||
| Stock-based compensation | 6,416,378 | 4,583,632 | 18,675,208 | 4,583,632 | ||||||||||||
| Business acquisition costs | 1,948,118 | — | 3,273,118 | — | ||||||||||||
| Unrealized (gain) loss on equity securities, at fair value | (417,677 | ) | 306,800 | (1,220,161 | ) | (491,356 | ) | |||||||||
| Realized gain on equity securities, at fair value | — | — | (856,744 | ) | — | |||||||||||
| Loss (gain) on change in fair value of debt | 124,237 | (2,088,797 | ) | 4,036,327 | 309,865 | |||||||||||
| Adjusted EBITDA | $ | 16,666,306 | $ | 10,796,500 | $ | 44,959,403 | $ | 28,231,248 | ||||||||
| Adjusted EBITDA margin | 59.2 | % | 51.1 | % | 57.1 | % | 66.1 | % | ||||||||
| Net (loss) income margin | (18.8 | )% | 5.0 | % | (7.5 | )% | 36.1 | % | ||||||||
ABACUS LIFE, INC. Adjusted Return on Invested Capital (ROIC)
| For the period ended | For the period ended | |||||||
| June 30, 2024 | September 30, 2024 | |||||||
| Total Assets | $ | 483,854,905 | $ | 477,309,168 | ||||
| Less: | ||||||||
| Intangible assets, net | (26,352,123 | ) | (24,653,141 | ) | ||||
| Goodwill | (139,930,190 | ) | (139,930,190 | ) | ||||
| Total current liabilities | (55,383,057 | ) | (23,862,348 | ) | ||||
| Total Invested Capital | $ | 262,189,535 | $ | 288,863,489 | ||||
| Adjusted Net Income | $ | 11,812,527 | $ | 14,879,252 | ||||
| Adjusted Annualized ROIC | 18.0 | % | 20.6 | % | ||||
ABACUS LIFE, INC. Adjusted Return on Equity (ROE)
| For the period ended | For the period ended | |||||||
| June 30, 2024 | September 30, 2024 | |||||||
| Total stockholders' equity | $ | 256,849,488 | $ | 257,939,628 | ||||
| Adjusted Net Income | $ | 11,812,527 | $ | 14,879,252 | ||||
| Adjusted Annualized ROE | 18.4 | % | 23.1 | % | ||||
FAQ
What was Abacus Life's (ABL) revenue growth in Q3 2024?
Why did Abacus Life (ABL) report a net loss in Q3 2024?
How many policy originations did Abacus Life (ABL) achieve in Q3 2024?
What acquisitions is Abacus Life (ABL) planning to complete in Q4 2024?
